Category : Animal Health

MSD Animal Health Acquires LICA’s Assets to Enhance its Dairy

Tuba Khan June 8, 2021

Shots: MSD acquires the LICA’s assets for $27.64M. The transaction is expected to be complete on Jun 11, 2021 The acquisition will boost MSD’s veterinary medicines, vaccines, and health management solutions/ services, and Allflex Livestock Intelligence’s digitally connected identification, traceability, and monitoring products to benefit farmers and veterinarians LICA’s product portfolio joins Allflex Livestock Intelligence […]Read More

Animal Health

FSD Pharma Signs a License Agreement with Innovet to Develop

Tuba Khan March 18, 2021

Shots: Innovet to receive non-refundable sum of $500,000 which is payable on the effective date of the agreement and a second non-refundable sum of $250,000 which is payable on the first anniversary of the effective date of the agreement Within 30days, post first notification of the FDA on NDA’s approval of the first licensed product, […]Read More

Animal Health

Boehringer Ingelheim Animal Health Establishes Pawru for its PetPro Portfolio

Tuba Khan February 17, 2021

Shots: The Pawru will accelerate the expansion of Boehringer Ingelheim’s digital animal healthcare platform, k/a PetPro Connect. PetPro portfolio will transition to Pawru branding The Pawru explores the strategic partners to expand its commercial offerings. PetPro Connect provides the service as a mobile app that links them with their veterinarians for telemedicine appointments, prescription refills, […]Read More

Animal Health Regulatory

QBiotics’ Stelfonta (tigilanol tiglate) Receives the US FDA’s Approval as

Tuba Khan November 17, 2020

Shots: The approval is based on a study supporting its safety, efficacy in dogs with a measurable cutaneous/ SC MCT on the lower leg and follows the EMA’s MAA granted in early 2020 Stelfonta provides 75% complete tumor resolution after just one injection, and dogs quickly regain pre-treatment QoL. The therapy will be launched in […]Read More

Animal Health

Boehringer Ingelheim Acquires GST to Boost its Stem Cell Capabilities

Tuba Khan August 10, 2020

Shots: Boehringer Ingelheim has acquired Global Stem cell Technology (GST) focusing to strengthen its portfolio capabilities to accelerate innovation and growth The acquisition follows two years of partnership b/w the companies that brought the first-ever registered stem cell-based veterinary medicine (Arti-Cell Forte) in the EU The acquisition of GST will accelerate the development pipeline of […]Read More

Animal Health

Elanco Receives the US FTC’s Approval for Acquisition of Bayer

Tuba Khan July 15, 2020

Shots: Elanco has received the US FTC’s approval for its acquisition of Bayer Animal Health, representing the final antitrust clearance needed to complete the transaction, which continues track for closing at the beginning of August The FTC’s approval follows divestiture of global rights for Osurnia to treat otitis externa in dogs, US rights for Capstar […]Read More

Animal Health

Merck Animal Health Receives the US FDA’s Approval for Bravecto

Tuba Khan July 9, 2020

Shots: The US FDA approves Bravecto 1-month (fluralaner) chews for dogs and puppies aged≥ 8 weeks. The approval will expand Merck’s parasiticide portfolio, which are extended duration flea and tick protection products offering parasite protection for dogs The product is suitable for dogs in the early stages of life to begin a regimen of monthly […]Read More

Animal Health

Boehringer Ingelheim Receives Approval for its Classical Swine Fever Live

Tuba Khan June 10, 2020

Shots: Boehringer’s Ingelvac CSF MLV has obtained a New Veterinary Drug Registration Certificate from the Ministry of Agriculture and Rural Affairs of China The vaccine is jointly developed by Boehringer and Chinese research institutes and will be produced at BI’s Taizhou plant, Jiangsu province, and is expected to be commercialized in H1’21 The vaccine is […]Read More

Animal Health

Elanco Receives EC’s Approval for its Pending Acquisition of Bayer

Vartika Singh June 8, 2020

Shots: The EC has granted approval of Elanco’s pending acquisition of Bayer’s animal health business. The company continues to progress toward a mid-year closing, anticipated Aug 03, 2020 The EC’s approval follows the divestiture of global rights for Osurnia to treat otitis externa in dogs, WW rights of Vecoxa to prevent & treat coccidiosis in […]Read More

Animal Health

Merck Animal Health to Acquire Rights to Sentinel Brand of

Tuba Khan May 13, 2020

Shots: Merck Animal Health to acquire the US rights to Sentinel flavor tabs and chews in the companion animal category, under the agreement with Virbac. The transaction is expected to be closed by mid-2020 With the acquisition, Merck expects to provide veterinarians continuous parasite protection for dogs in easy to administer, palatable formulations The products […]Read More

CytoReason Collaborates with Sanofi to Initiate its Project Utilizing AI Technology for Asthma

Atea Pharma Secures $50M Milestone Payment with Roche in the Development of AT-527 for COVID-19

ViiV Healthcare Signs a License Agreement with Halozyme for ENHANZE Drug Delivery Technology to Develop Ultra Long-Acting Medicines for HIV

Arrowhead Signs a License Agreement with Horizon to Develop siRNA Therapeutic Targeting XDH for Uncontrolled Gout

Innovent Publishes the Results of Sintilimab + IBI305 (bevacizumab, biosimilar) in P-II/III ORIENT-32 Study as 1L Treatment for HCC in The Lancet Oncology

Celltrion Presents Real-World Data of Truxima (biosimilar, rituximab) for Diffuse Large B-Cell Lymphoma at EHA 2021

GSK and Vir Report Results of Sotrovimab in P-III COMET-ICE Trial for High-Risk Adult Patients with Mild-To-Moderate COVID-19

Atea Pharma Secures $50M Milestone Payment with Roche in the Development of AT-527 for COVID-19

LEO Pharma’ Adtralza (tralokinumab) Receives EC’s Approval for Moderate-To-Severe Atopic Dermatitis

AstraZeneca and MSD’s Koselugo (selumetinib) Receive the EU’s Approval for Neurofibromatosis Type 1 and Plexiform Neurofibromas

Novartis Reports New Data of Kesimpta (ofatumumab) in ALITHIOS Study for Multiple Sclerosis

GSK and Vir Report Results of Sotrovimab in P-III COMET-ICE Trial for High-Risk Adult Patients with Mild-To-Moderate COVID-19

Category : Animal Health

MSD Animal Health Acquires LICA’s Assets to Enhance its Dairy

FSD Pharma Signs a License Agreement with Innovet to Develop

Boehringer Ingelheim Animal Health Establishes Pawru for its PetPro Portfolio

QBiotics’ Stelfonta (tigilanol tiglate) Receives the US FDA’s Approval as

Boehringer Ingelheim Acquires GST to Boost its Stem Cell Capabilities

Elanco Receives the US FTC’s Approval for Acquisition of Bayer

Merck Animal Health Receives the US FDA’s Approval for Bravecto

Boehringer Ingelheim Receives Approval for its Classical Swine Fever Live

Elanco Receives EC’s Approval for its Pending Acquisition of Bayer

Merck Animal Health to Acquire Rights to Sentinel Brand of

Latest Posts

Novartis Reports New Data of Kesimpta (ofatumumab) in ALITHIOS Study for Multiple Sclerosis

LEO Pharma’ Adtralza (tralokinumab) Receives EC’s Approval for Moderate-To-Severe Atopic Dermatitis

ViewPoints Interview: Myriad Genetics’ Thomas Slavin Shares Insights on the Data Validating Breast Cancer PRS Across Ancestries

GSK and Vir Report Results of Sotrovimab in P-III COMET-ICE Trial for High-Risk Adult Patients with Mild-To-Moderate COVID-19

Category : Animal Health

Latest Posts

Categories

Related Topics